These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6718653)

  • 21. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.
    Daugherty CK; Ratain MJ; Emanuel EJ; Farrell AT; Schilsky RL
    J Clin Oncol; 2008 Mar; 26(8):1371-8. PubMed ID: 18227527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical aspects of clinical comparative experiments].
    Strnad L
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1988; 31(4):529-42. PubMed ID: 3249937
    [No Abstract]   [Full Text] [Related]  

  • 23. Methods and models for placebo use in pharmacotherapeutic trials.
    Prien RF
    Psychopharmacol Bull; 1988; 24(1):4-8. PubMed ID: 3290947
    [No Abstract]   [Full Text] [Related]  

  • 24. I've heard the term "placebo" used in news stories about research studies. What is it?
    Mayo Clin Health Lett; 2000 Sep; 18(9):8. PubMed ID: 10967729
    [No Abstract]   [Full Text] [Related]  

  • 25. [Sensible use of placebo in psychopharmacological research].
    Kotler M; Witztum E
    Harefuah; 1999 May; 136(9):692-4. PubMed ID: 10955091
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of placebo assignment in clinical trials of Parkinson's disease.
    Goetz CG; Janko K; Blasucci L; Jaglin JA
    Mov Disord; 2003 Oct; 18(10):1146-9. PubMed ID: 14534918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and analysis of prostate cancer trials.
    Sylvester R
    Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
    D'Agostino RB; Massaro JM; Sullivan LM
    Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proceedings of the Symposium on Designs for Clinical Cancer Reseach. Discussion I: Basic design considerations.
    Cancer Treat Rep; 1980; 64(2-3):411-7. PubMed ID: 7407778
    [No Abstract]   [Full Text] [Related]  

  • 30. Rationale for a non-inferiority clinical trial design focused on subpopulations.
    Kulkarni PM; Meadows ES; Ahuja S; Muram D; Plouffe L
    Curr Med Res Opin; 2004 Oct; 20(10):1641-7. PubMed ID: 15462697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Controlled therapeutic trials: elaboration of the protocol].
    Rodary M
    Rev Prat; 1983 Apr; 33(19):963-4, 967-8, 971-3. PubMed ID: 6867568
    [No Abstract]   [Full Text] [Related]  

  • 32. Current issues in non-inferiority trials.
    Fleming TR
    Stat Med; 2008 Feb; 27(3):317-32. PubMed ID: 17340597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A framework for two-stage adaptive procedures to simultaneously test non-inferiority and superiority.
    Koyama T; Sampson AR; Gleser LJ
    Stat Med; 2005 Aug; 24(16):2439-56. PubMed ID: 15977285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The necessary number of groups for observations in controlled clinical research. Groups with equal numbers].
    Dvoĭrin VV; Basieva TKh; Gulaia VI
    Vopr Onkol; 1984; 30(2):3-8. PubMed ID: 6702128
    [No Abstract]   [Full Text] [Related]  

  • 35. Are two antidepressant mechanisms better than one? Issues in clinical trial design and analysis.
    Leon AC
    J Clin Psychiatry; 2004; 65 Suppl 4():31-6. PubMed ID: 15046539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Placebo-free designs for evaluating new mental health treatments: the use of adaptive treatment strategies.
    Dawson R; Lavori PW
    Stat Med; 2004 Nov; 23(21):3249-62. PubMed ID: 15490427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The placebo in therapeutic trials].
    Duchier J
    Rev Prat; 1980 Feb; 30(7):333-8. PubMed ID: 7361043
    [No Abstract]   [Full Text] [Related]  

  • 38. [The importance of equivalence trials in showing the usefulness of treatments].
    Hermens ML; van Hout HP; Terluin B; Adèr HJ; de Haan M
    Ned Tijdschr Geneeskd; 2003 Nov; 147(44):2162-6. PubMed ID: 14626832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the impact of ICH E9.
    Brown D; Day S; Hemmings R; Wright D
    Pharm Stat; 2008; 7(2):77-87. PubMed ID: 18438957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proceedings of the Symposium on Designs for Clinical Cancer Research. Perspective of the clinician.
    Hoogstraten B
    Cancer Treat Rep; 1980; 64(2-3):537-8. PubMed ID: 7407796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.